US 7531623
Hydrochloride salts of a glycopeptide phosphonate derivative
granted A61PA61P31/00A61P31/04
Quick answer
US patent 7531623 (Hydrochloride salts of a glycopeptide phosphonate derivative) held by Theravance, Inc. expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P31/00, A61P31/04